Literature DB >> 21987752

Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options.

Paul Roddy1, Robert Colebunders, Benjamin Jeffs, Pedro Pablo Palma, Michel Van Herp, Matthias Borchert.   

Abstract

Testing an innovative therapy for filovirus hemorrhagic fever (FHF) in an outbreak setting may be years away. Moreover, beyond anecdotal evidence, little is known about best practice for outbreak case management. Currently, Médecins Sans Frontières and others provide FHF patients with basic supportive treatment. We describe and discuss treatment possibilities, challenges, and potential next steps for FHF outbreak case management. More comprehensive supportive treatment, including vital sign monitoring, intensive care components, and goal-directed interventions may contribute to improved clinical outcome; the feasibility and effectiveness of this more comprehensive supportive treatment should be assessed. Our outlined summary may assist future FHF outbreak case management teams to create collaborative platforms and develop relevant treatment protocols aimed at improving clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987752     DOI: 10.1093/infdis/jir297

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Authors:  Edgar Davidson; Christopher Bryan; Rachel H Fong; Trevor Barnes; Jennifer M Pfaff; Manu Mabila; Joseph B Rucker; Benjamin J Doranz
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 2.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

3.  Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

Authors:  Aileen O'Hearn; Minxiu Wang; Han Cheng; Calli M Lear-Rooney; Katie Koning; Emily Rumschlag-Booms; Elizabeth Varhegyi; Gene Olinger; Lijun Rong
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Ebola virus disease: What clinicians in the United States need to know.

Authors:  William A Fischer; Timothy M Uyeki; Robert V Tauxe
Journal:  Am J Infect Control       Date:  2015-06-24       Impact factor: 2.918

5.  Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network.

Authors:  Andrea K Boggild; Douglas H Esposito; Phyllis E Kozarsky; Vernon Ansdell; Nicholas J Beeching; Daniel Campion; Francesco Castelli; Eric Caumes; Francois Chappuis; Jakob P Cramer; Effrossyni Gkrania-Klotsas; Martin P Grobusch; Stefan H F Hagmann; Noreen A Hynes; Poh Lian Lim; Rogelio López-Vélez; Denis J M Malvy; Marc Mendelson; Philippe Parola; Mark J Sotir; Henry M Wu; Davidson H Hamer
Journal:  Ann Intern Med       Date:  2015-06-02       Impact factor: 25.391

6.  A call to action to enhance filovirus disease outbreak preparedness and response.

Authors:  Paul Roddy
Journal:  Viruses       Date:  2014-09-30       Impact factor: 5.048

Review 7.  Clinical management of filovirus-infected patients.

Authors:  Danielle V Clark; Peter B Jahrling; James V Lawler
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

8.  Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.

Authors:  Paul Roddy; Natasha Howard; Maria D Van Kerkhove; Julius Lutwama; Joseph Wamala; Zabulon Yoti; Robert Colebunders; Pedro Pablo Palma; Esther Sterk; Benjamin Jeffs; Michel Van Herp; Matthias Borchert
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 9.  Potential vaccines and post-exposure treatments for filovirus infections.

Authors:  Brian M Friedrich; John C Trefry; Julia E Biggins; Lisa E Hensley; Anna N Honko; Darci R Smith; Gene G Olinger
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

10.  Clinical documentation and data transfer from Ebola and Marburg virus disease wards in outbreak settings: health care workers' experiences and preferences.

Authors:  Silja Bühler; Paul Roddy; Ellen Nolte; Matthias Borchert
Journal:  Viruses       Date:  2014-02-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.